Simplex Trading
NVLN

Simplex Trading’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Simplex Trading’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$7K – 9229
2019
Q2 		$7K Buy
10,000
+9,583
+2,298% +$10.7K ﹤0.01% 6335
2019
Q1 		$0 Buy
+417
New +$475 ﹤0.01% 9107
2018
Q4 		– Hold
0
– – – 9030
2018
Q3 		– Hold
0
– – – 9195
2018
Q2 		– Sell
-2,384
Closed -$8K – 8923
2018
Q1 		$8K Buy
+2,384
New +$10.1K ﹤0.01% 4280
2017
Q4 		– Hold
0
– – – 7893
2017
Q3 		– Hold
0
– – – 7910
2017
Q2 		– Sell
-6,819
Closed -$65.7K – 7985
2017
Q1 		$73K Buy
6,819
+651
+11% +$6.65K ﹤0.01% 2025
2016
Q4 		$51K Buy
+6,168
New +$54.6K 0.01% 2142

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return
HCM
Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return